International Agency for Research on Cancer (IARC) - Summaries & Evaluations
VOL.: 10 (1976) (p. 217)
5. Summary of Data Reported and Evaluation
5.1 Animal carcinogenicity data
No adequate tests to assess the carcinogenicity of reserpine in
experimental animals were available to the Working Group.
5.2 Human carcinogenicity data
Results from a number of epidemiological studies are not consistent in
indicating an increased risk of cancer in patients exposed to
Rauwolfia derivatives, and any conclusion about the existence of a
risk should await further evidence.
Vol. 24 (1980);
Suppl. 7 (1987)
Last updated: 22 March 1998